Vytrus Biotech S.A. (VYT) — Cash Flow Reinvestment Rate
Vytrus Biotech S.A. (VYT) has a Cash Flow Reinvestment Rate of 2.19x as of December 2022, reinvesting €494.16K (capex €494.16K ) from operating cash flow of €225.55K. See Vytrus Biotech S.A. (VYT) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Vytrus Biotech S.A. Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for Vytrus Biotech S.A. across 5 annual periods. For the full cash flow conversion analysis, see Vytrus Biotech S.A. (VYT) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Vytrus Biotech S.A. (2021–2025)
Year-by-year capital reinvestment analysis for Vytrus Biotech S.A.. See financial flexibility index of Vytrus Biotech S.A. to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.71x | €2.76 Million | €3.90 Million | €2.68 Million | ▲ +8.1% |
| 2024 | 0.65x | €1.21 Million | €1.84 Million | €1.20 Million | ▼ -49.9% |
| 2023 | 1.31x | €1.18 Million | €904.39K | €1.17 Million | ▼ -44.0% |
| 2022 | 2.33x | €526.44K | €225.55K | €494.16K | ▲ +245.3% |
| 2021 | 0.68x | €302.78K | €447.92K | €271.82K | — |